Ect2, which has activity for multiple members of the Rho GTPase family including RhoA, Rac1 and Cdc42, has been recognized as an oncogene in human cancer since 2010, being aberrantly overexpressed and mislocalised in various types of tumors.47 This evidence concerns the gene RAC1 and cancer.